Recalls · Brand

King Legacy, a wholly owned subsidiary of Pfizer recalls

Every recall we track for King Legacy, a wholly owned subsidiary of Pfizer — 11 in all — plus the complaints and injury reports the public filed about them.

11recalls

187complaints & reports

84injuries reported

10deaths reported

All King Legacy, a wholly owned subsidiary of Pfizer recalls

11 shown

ℹ️ UnratedDrug
King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 125 mcg, packaged in a) 100-count bottles (NDC 60793-856-01) and b)
King Legacy, a wholly owned subsidiary of PfizerApr 30, 2013
ℹ️ UnratedDrug
King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 100 mcg, packaged in a) 100-count bottles (NDC 60793-854-01) and b)
King Legacy, a wholly owned subsidiary of PfizerApr 30, 2013
ℹ️ UnratedDrug
King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 75 mcg, packaged in a) 100-count bottles (NDC 60793-852-01) and b)
King Legacy, a wholly owned subsidiary of PfizerApr 30, 2013
ℹ️ UnratedDrug
King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and b)
King Legacy, a wholly owned subsidiary of PfizerApr 30, 2013
ℹ️ UnratedDrug
King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 150 mcg, packaged in a) 100-count bottles (NDC 60793-858-01) and b)
King Legacy, a wholly owned subsidiary of PfizerApr 30, 2013
ℹ️ UnratedDrug
King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and b)
King Legacy, a wholly owned subsidiary of PfizerApr 30, 2013
ℹ️ UnratedDrug
King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 112 mcg, packaged in a) 100-count bottles (NDC 60793-855-01) and b)
King Legacy, a wholly owned subsidiary of PfizerApr 30, 2013
ℹ️ UnratedDrug
King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 25 mcg, packaged in a) 100-count bottles (NDC 60793-850-01) and b)
King Legacy, a wholly owned subsidiary of PfizerApr 30, 2013
ℹ️ UnratedDrug
King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b)
King Legacy, a wholly owned subsidiary of PfizerApr 30, 2013
ℹ️ UnratedDrug
King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 88 mcg, packaged in a) 100-count bottles (NDC 60793-853-01) and b)
King Legacy, a wholly owned subsidiary of PfizerApr 30, 2013
ℹ️ UnratedDrug
King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b)
King Legacy, a wholly owned subsidiary of PfizerApr 30, 2013

King Legacy, a wholly owned subsidiary of Pfizer recalls

All King Legacy, a wholly owned subsidiary of Pfizer recalls

King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 125 mcg, packaged in a) 100-count bottles (NDC 60793-856-01) and b)

King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 100 mcg, packaged in a) 100-count bottles (NDC 60793-854-01) and b)

King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 75 mcg, packaged in a) 100-count bottles (NDC 60793-852-01) and b)

King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and b)

King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 150 mcg, packaged in a) 100-count bottles (NDC 60793-858-01) and b)

King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and b)

King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 112 mcg, packaged in a) 100-count bottles (NDC 60793-855-01) and b)

King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 25 mcg, packaged in a) 100-count bottles (NDC 60793-850-01) and b)

King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b)

King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 88 mcg, packaged in a) 100-count bottles (NDC 60793-853-01) and b)

King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b)